Clinical Trials Sponsored by OYA GUMUSKAYA BRADLEY
Total 1 results
-
OYA GUMUSKAYA BRADLEYCompletedPostoperative Nausea and VomitingTurkey
Sponsors and Collaborators
- King Saud University
- YuceBio Technology Co., Ltd.
- Zogenix, Inc.
- CARERS TRUST (Carers Trust), UK
- Home care nursing in the Municipality of Esbjerg
- Chin-Tsung Shen
- Michael Zell, MD
- Institute of Population Research, Peking University
- Department of Gastroenterology, "Grigore T. Popa" University of Medicine and Pharmacy, Romania
- Louisville VA Medical Center
- West of Scotland Lymphoma Group
- OLVG
- Allorion Therapeutics Inc
- Momotaro-Gene Inc.
- Pak Emirates Military Hospital Rawalpindi
- Mrs Hiroko Yuzawa, MD, PhD(c); Department of Intensive Care Medicine, Tokyo, Japan
- Cook County Health & Hospitals System
- S&T Medical Technologies, Inc.
- Barth Wilsey
- Common Room Consulting Ltd
- View Full List
Medical Conditions
- Malalignment, Bone
- Metastatic or Recurrent Head and Neck Squamous Cell Cancer
- Granulocyte/ Polymorphonuclear Cells
- Complications, Postoperative
- Polyneuropathy and Mononeuropathies
- Focus of the Study is Satiety
- Infant Amino Acid Profile at Day 3 and Discharge
- Degenerative Lumbar Diseases
- Antiphospholipid Syndrome
- COPD - Chronic Obstructive Pulmonary Disease
- Excitotoxicity
- Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV 2 Infection)
- HODGKIN LYMPHOMA
- Locally Advanced or Metastatic Prostate Cancer.
- Solid Tumors With Documented BRCA, BARD, or PALB or Other Acceptable DNA Mutations or Anomalies That Are Scientifically Sound
- Sexual Wellbeing
- Platelet-aggregation Inhibitors
- Caridovascular Disease
- Peripheral Microvascular Symptoms
- HR+HER2- Breast Cancer
- View Full List
Drug Interventions
- Plerixafor
- Local medical treatment of raised intraocular pressure
- 120 mg Pseudoephedrine hydrochloride extended release tablets
- Standard care Hyaluronic acid eye drops
- PP4001
- Gardasil
- Erenumab Dose 2
- Linagliptin
- Pre-study antiretroviral regimen
- Intensive chemotherapy
- Lamictal
- GSK1247303
- IDX-1197
- Pleyris
- HM30181AK 15mg
- Nilotinib 400 mg BID
- Dexmedetomidine injection
- Pulmozyme
- 4-Demethyl-4-cholestryloxycarbonylpenclomedine
- Cohort 2 Probe Substrate
- View Full List
CROs by country
- Contract Research Organizations in Armenia
- Contract Research Organizations in Benin
- Contract Research Organizations in Bosnia & Herzegovina
- Contract Research Organizations in China
- Contract Research Organizations in Lithuania
- Contract Research Organizations in Malawi
- Contract Research Organizations in Malaysia
- Contract Research Organizations in Mauritania
- Contract Research Organizations in Norway
- Contract Research Organizations in Singapore
- Contract Research Organizations in Slovenia
- Contract Research Organizations in Sri Lanka
- Contract Research Organizations in Zambia
- CRO list by country